Lifeclinic: Blood Pressure Monitors & Health Stations
HomeBlood PressureCholesterolDiabetesNutritionSenior Care
Key Word Search
 
Basic Facts
How to Lower It
Monitoring Your BP
Visiting Your Doctor
Risk Factors
Low Blood Pressure
Hypertension & Pregnancy
Stroke
Heart Failure
My Health Record
FREE
Blood Pressure Health Station Locator
Locate a Dealer
Resources
Cookbook
Hypertension Dictionary
Health News
Reminders
My Saved Articles
Links
About Us
Contact Us
Press Releases
Advertising
Terms of Use
Privacy Policy
 

Hormone replacement therapy and cardiovascular disease in post-menopausal women

By: Thomas Pickering, MD, DPhil, FRCP, Director of Integrative and Behavioral Cardiology Program
of the Cardiovascular Institute at Mount Sinai School of Medicine, New York.

While it is well established that estrogen therapy reduces the risk of heart disease in post-menopausal women, there has been considerable doubt as to whether combined estrogen and progestin therapy confers the same benefit. The combination is recommended for women who have not had a hysterectomy, because estrogen on its own may increase the risk of cancer of the uterus.

This study was part of the Nurses' Health Study, in which 59,337 nurses have been observed for up to 16 years. It was found that women who took both estrogen and progestin had about half the risk of a heart attack as women who took no hormones. Women who took estrogen alone were at similarly reduced risk. Neither estrogen alone nor the combination with progestin appeared to protect against strokes.

Doctor's comments

Estrogen tends to raise HDL cholesterol, which is one of the ways by which it may lower the risk of heart disease. Some earlier studies suggested that this benefit may be lost when it is combined with progestin, which may also raise the LDL (bad) cholesterol. It was therefore suspected that the combination of estrogen and progestin might not be good for heart disease. This study provides the most convincing evidence to date that the combination of estrogen and progestin is just as good as estrogen alone.

Where it was published

Grodstein F and colleagues. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. The New England Journal of Medicine. 1996;335:453-61.